Insulin-like growth factor binding PROTEIN-3

Biomarker

1 paper2 findings

MeSH D018972

  • Humans1

Associations

2

Colorectal adenoma

downin humans1RR 0.28

1 study
  1. Insulin-like growth factor binding PROTEIN-3 lowers the risk of colorectal adenoma in humans (RR 0.28, 95% CI 0.09-0.85).

    “women in the high tertile of IGFBP-3 were at lower risk of intermediate/late-stage colorectal adenoma (RR, 0.28; 95% CI, 0.09-0.85) and cancer (RR, 0.28; 95% CI, 0.10-0.83).”

    Humanshigh tertile vs low tertile, controlling for IGF-1 levelplasmafemales

    A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology1 Apr 2000

More on Colorectal adenoma

Colorectal cancer

downin humans1RR 0.28

1 study
  1. Insulin-like growth factor binding PROTEIN-3 lowers the risk of colorectal cancer in humans (RR 0.28, 95% CI 0.10-0.83).

    “women in the high tertile of IGFBP-3 were at lower risk of intermediate/late-stage colorectal adenoma (RR, 0.28; 95% CI, 0.09-0.85) and cancer (RR, 0.28; 95% CI, 0.10-0.83).”

    Humanshigh tertile vs low tertile, controlling for IGF-1 levelplasmafemales

    A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology1 Apr 2000

More on Colorectal cancer

Latest